Related Experiment Video
Updated: Jun 16, 2025

08:47
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
35.7K
Histone modifications in hypoxic ischemic encephalopathy: Implications for therapeutic interventions.
Yichen Ji1, Ye Tian2, Huiyi Zhang1
1Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China.
Life Sciences
|August 15, 2024
Summary
Histone modifications, including methylation and acetylation, are implicated in neonatal hypoxic-ischemic encephalopathy (HIE). Targeting these epigenetic changes offers a promising new therapeutic strategy for HIE treatment.
Area of Science:
- Neuroscience
- Epigenetics
- Neonatal Research
Background:
- Hypoxic-ischemic encephalopathy (HIE) is a critical neonatal brain injury resulting from oxygen deprivation.
- HIE's impact is severe in newborns due to ongoing brain development.
- Histone modifications are increasingly recognized as key players in the brain's response to acute stress and HIE development.
Purpose of the Study:
- To review the role of histone modifications in hypoxic-ischemic encephalopathy (HIE).
- To explore potential therapeutic strategies targeting histone modifications for HIE treatment.
Main Methods:
- Literature review focusing on histone modifications (methylation, acetylation, phosphorylation, crotonylation) in the context of HIE.
- Examination of histone deacetylase inhibitors as a potential HIE therapy.
Main Results:
- Four primary histone modifications are linked to HIE pathogenesis.
- Histone deacetylase inhibitors show potential efficacy in HIE treatment models.
Conclusions:
- Targeting histone modifications represents a novel strategy for understanding HIE mechanisms.
- Epigenetic modulation offers a promising new therapeutic avenue for treating HIE.
Related Concept Videos
Histone Modification
13.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.2K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K

